2026 NPPES data Specialist NPI 1174617625 M.D.
Verify on CMS →

RATNAVALI KOLLA, M.D.

Specialist in GAITHERSBURG, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 483 beneficiaries · Specialist avg: 1K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$2.7K
155 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RATNAVALI KOLLA, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 4,166 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
4K
Part D claims, 2023
92%
generic prescribing
$2.7K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RATNAVALI KOLLA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about RATNAVALI KOLLA, M.D.?

Below national average

NPI registry status

Active

Issued 10/02/2006

NPI 1174617625

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

4,166 183% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Maryland

How Specialist compares to other specialties among Maryland providers

Maryland providers

Specialist share within Maryland

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Maryland

Medicare quality performance — MIPS

RATNAVALI KOLLA, M.D.'s 2023 MIPS final score plotted against the Specialist national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Specialist) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RATNAVALI KOLLA, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 16003 COMPRINT CIR, GAITHERSBURG, MD, 20877, with a listed phone of (301) 869-2358. NPI 1174617625 was issued on 10/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KOLLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,166 prescription claims written by this provider, covering 483 Medicare beneficiaries and totaling roughly $920K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 0.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

16003 COMPRINT CIR
GAITHERSBURG, MD 20877

Provider Details

NPI 1174617625
Specialty Specialist
Credentials M.D.
Gender Female
NPI Issued 10/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RATNAVALI KOLLA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.7K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

RATNAVALI KOLLA, M.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 4,166 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,166
Total Claims
$920K
Total Drug Cost
483
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,639
Total Day Supply
165,883
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$740K
Generic Drug Cost
$180K
Opioid Claims
13 (0.3% rate)

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
1.44
Gender Split
62% female / 38% male
Age Distribution
<65: 98, 65-74: 170, 75-84: 154, 85+: 61

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RATNAVALI KOLLA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Gabapentin
630
Donepezil Hcl
337
Carbidopa-Levodopa
Carbidopa/Levodopa
205
Pregabalin
190
Escitalopram Oxalate
180
Memantine Hcl
179
Carbidopa-Levodopa Er
Carbidopa/Levodopa
148
Levetiracetam
144
Quetiapine Fumarate
140
Primidone
116

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How RATNAVALI KOLLA, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

RATNAVALI KOLLA, M.D.'s 4,166 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as KOLLA.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is RATNAVALI KOLLA, M.D.'s specialty?
RATNAVALI KOLLA, M.D. specializes in Specialist and practices in GAITHERSBURG, Maryland. Credentials: M.D..
How much does RATNAVALI KOLLA, M.D. prescribe under Medicare Part D?
In 2023, RATNAVALI KOLLA, M.D. wrote 4,166 Medicare Part D claims totaling $920K in drug costs for 483 beneficiaries.
What is RATNAVALI KOLLA, M.D.'s Medicare quality score?
RATNAVALI KOLLA, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RATNAVALI KOLLA, M.D. located?
RATNAVALI KOLLA, M.D. is located at 16003 COMPRINT CIR, GAITHERSBURG, MD, 20877. Phone: (301) 869-2358.
What is RATNAVALI KOLLA, M.D.'s NPI number?
RATNAVALI KOLLA, M.D.'s National Provider Identifier (NPI) is 1174617625, issued on 10/02/2006.
Does RATNAVALI KOLLA, M.D. prescribe more brand-name or generic drugs?
RATNAVALI KOLLA, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $740K in brand drug costs.
Does RATNAVALI KOLLA, M.D. prescribe opioids?
Yes, RATNAVALI KOLLA, M.D. had 13 opioid claims in 2023 with an opioid prescribing rate of 0.3%.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does RATNAVALI KOLLA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RATNAVALI KOLLA, M.D.'s most frequently prescribed drugs include Gabapentin, Donepezil Hcl, Carbidopa-Levodopa. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RATNAVALI KOLLA, M.D. accept Medicare?
RATNAVALI KOLLA, M.D. appears in CMS Medicare data with 4,166 Part D claims and 483 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RATNAVALI KOLLA, M.D.'s credentials?
RATNAVALI KOLLA, M.D.'s NPI is 1174617625 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology